Very important and practically oriented paper Nice overview of advantages and limitations A must read for anybody who treats these patients To view or add a comment, sign in GLP-1RAs Show Significant Liver and Metabolic Benefits in MASLD A new systematic review and meta-analysis of 32 randomized controlled trials reveals that GLP-1 receptor agonists (GLP-1RAs) significantly improve liver and metabolic outcomes in patients with Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), far outperforming DPP-4 inhibitors, which showed minimal effects beyond glycemic control
Your nurse practitioner reviews criteria, contraindications, risks, side effects, and alternatives
Walking mostly
The peptide has been studied extensively in animal models for over two decades, with research focusing on its remarkable tissue-healing properties
The most common microdose protocols use 0.0625 mg, 0.1 mg, 0.125 mg, or 0.15 mg per week
Shelf Life of Semaglutide Compound: Storage and Stability Assigning a safe fridge life requires hard testing, not assumptions